Loading...
XESM
UPR
Market cap1.14bUSD
Jul 11, Last price  
3.76EUR
1D
-2.59%
1Q
49.21%
IPO
221.37%
Name

Uniphar PLC

Chart & Performance

D1W1MN
P/E
15.20
P/S
0.35
EPS
0.25
Div Yield, %
0.49%
Shrs. gr., 5y
8.27%
Rev. gr., 5y
10.72%
Revenues
2.77b
+8.51%
639,639,000860,495,0001,128,759,0001,117,248,0001,296,320,0001,267,418,0001,552,100,0001,665,283,0001,823,854,0001,943,149,0002,070,669,0002,553,062,0002,770,429,000
Net income
64m
+43.26%
-4,583,000-17,854,000-19,481,0005,946,0005,738,000-1,028,00017,300,00021,026,00027,827,00048,077,00045,587,00044,815,00064,203,000
CFO
124m
+136.65%
13,034,00014,273,00014,720,00025,999,00023,697,000-1,683,000-8,738,000106,997,00065,978,00052,177,00082,831,00052,511,000124,268,000
Dividend
Sep 12, 20240.0067 EUR/sh
Earnings
Sep 01, 2025

Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which provides access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that offers bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
URL
https://www.uniphar.ie/
IPO date
Jul 17, 2019
Employees
2,800
Domiciled in
IE
Incorporated in
IE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,770,429
8.51%
2,553,062
23.30%
2,070,669
6.56%
Cost of revenue
2,685,779
2,476,260
2,018,580
Unusual Expense (Income)
NOPBT
84,650
76,802
52,089
NOPBT Margin
3.06%
3.01%
2.52%
Operating Taxes
11,358
7,750
8,970
Tax Rate
13.42%
10.09%
17.22%
NOPAT
73,292
69,052
43,119
Net income
64,203
43.26%
44,815
-1.69%
45,587
-5.18%
Dividends
(5,076)
(4,832)
(4,666)
Dividend yield
0.88%
0.66%
0.55%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
31,896
33,302
21,805
Long-term debt
529,450
494,904
413,584
Deferred revenue
Other long-term liabilities
8,984
33,290
94,060
Net debt
458,329
442,529
331,660
Cash flow
Cash from operating activities
124,268
52,511
82,831
CAPEX
(79,734)
(21,258)
(19,921)
Cash from investing activities
(96,479)
(90,428)
(106,332)
Cash from financing activities
(11,488)
19,630
50,405
FCF
20,548
91,511
(38,661)
Balance
Cash
102,992
85,652
103,704
Long term investments
25
25
25
Excess cash
196
Stockholders' equity
210,582
150,872
113,282
Invested Capital
817,019
748,899
694,212
ROIC
9.36%
9.57%
6.75%
ROCE
10.36%
10.26%
7.50%
EV
Common stock shares outstanding
273,015
273,015
272,557
Price
2.12
-21.48%
2.70
-12.90%
3.10
-38.00%
Market cap
578,792
-21.48%
737,140
-12.76%
844,927
-37.36%
EV
1,037,247
1,180,488
1,176,826
EBITDA
120,014
112,208
80,559
EV/EBITDA
8.64
10.52
14.61
Interest
25,486
22,083
9,290
Interest/NOPBT
30.11%
28.75%
17.83%